Neurodiagnostics Market Analysis, Opportunities by 2031
The Neurodiagnostics Market is expected to register a CAGR of 7.5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report presents an analysis based on by Product (Diagnostic Imaging Systems, Clinical Diagnostic Instruments, Reagents and Consumables); Indication (Neurodegenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders); End User (Hospitals and Surgical Centers, Diagnostic Laboratories and Imaging Centers, Neurology Centers, Ambulatory Care Centers, Research Laboratories and Academic Institutes). The global analysis is further broken-down at regional level and major countries. The market size and forecast at global, regional, and country levels for all the key market segments are covered under the scope. The report offers the value in USD for the above analysis and segments. The report provides key statistics on the market status of the key market players and offers market trends and opportunities.
Purpose of the ReportThe report Neurodiagnostics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Neurodiagnostics Market Segmentation
Product- Diagnostic Imaging Systems
- Clinical Diagnostic Instruments
- Reagents and Consumables
- Neurodegenerative Diseases
- Epilepsy
- Stroke
- Headache Disorders
- Sleep Disorders
- Hospitals and Surgical Centers
- Diagnostic Laboratories and Imaging Centers
- Neurology Centers
- Ambulatory Care Centers
- Research Laboratories and Academic Institutes
Strategic Insights
Neurodiagnostics Market Growth Drivers- Rising cases of neurological disorders: The market for neurodiagnostics is driven by the increasing incidence of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and epilepsy. This is attributed to the aging of the global population, which triggers a significant need for practical diagnostic tools that can identify and monitor such conditions. As a result, healthcare providers are encouraged to invest in advanced technologies in neurodiagnostic, thereby significantly improving patient care and hence triggering growth in the market.
- Advancements in Technology: High-resolution imaging techniques and portable diagnostic devices are changing the landscape of neurodiagnostic technologies. Innovations such as functional MRI and electroencephalography improvements lead to better early detection and diagnosis of neurological conditions. Healthcare providers are widely accepting the easier availability and use of these technologies, so this is augmenting growth in the neurodiagnostics market.
- Better Awareness and Early Diagnosis: In recent times, prevention and early detection have become the focus of healthcare related to neurological disorders. High awareness among healthcare workers and patients about the importance of timely diagnosis drives demand for neurodiagnostic tools. Educational programs and outreach schemes take a long way to get people to seek an evaluation much earlier, and consequently, uptake for neurodiagnostic services and equipment increases.
- Integrated artificial intelligence: Furthermore, integration with artificial intelligence changes the face of neurodiagnostics; this innovation comes with outstanding excellence regarding accuracy and efficiency in the process of diagnosis. Radiologists use complex algorithms from the data of images to identify abnormalities among patients. Thus, this trend promises more excellent outcomes to the patients and smooth workflow so that neurodiagnostic processes are fast and reliable.
- Point-of-Care Testing: This will be a significant shift towards neurodiagnostics point-of-care testing wherein the patient can be diagnosed much more quickly and comfortably with their neurological disorder. It has developed portable devices and diagnostic equipment that will help to facilitate the testing of patients at the point of care. It can be used in an emergency room or outpatient clinic. It may come along with values that result from early intervention and monitoring, which is critical, especially with acute conditions that really impart high values to the speed of diagnosis.
- Increasing interest in telehealth solutions: Telehealth solutions have increasingly found neurodiagnostic applications across various neurodiagnostic fields. However, the COVID-19 pandemic created pressure on these solutions. Virtual consultation and remote monitoring technologies are becoming intrinsic components of the diagnosis and management of neurological disorders. This trend is fostering access for patients located in rural or other underserved locations so that barriers to timely and effective care may be broken.
- Biomarker Research Expansion: Biomarker research in neurological disorders has generated a good amount of potential in the neurodiagnostics market. More and more new biomarkers discovered and associated with different conditions may suggest a trend that should develop targeted tests that may improve early detection processes and, through their approaches, possibly also create more customization in treatment. Eventually, it is likely to increase the demand for new neurodiagnostic products and improvements in patient outcomes.
- Rise of Wearable Technologies: Indeed, the growth in wearables unlocks a pretty niche opportunity in neuro diagnostics. Monitoring devices that are capable of tracking neurological parameters as set by the product, such as EEG headbands or even tracing patterns of movement through smartwatches, are able to keep patients under continuous monitoring. This type of technology allows patients to control their conditions much better, and healthcare providers are able to generate precious information used in making decisions, hence fuelling growth and innovation within the space of neurodiagnostics.
- Partner with pharmaceutical companies: There is more scope for collaboration between neurodiagnostic companies and pharmaceutical firms with regard to companion diagnostics. By collaborating in developing tests to identify the appropriate patients who should receive the associated treatments, the firms can increase the efficiency of drugs and fast-track clinical trials. This provides an opportunity for many synergies: improvement in patient care outcomes with the encouragement of innovation in neurodiagnostics, which would continue to fuel growth in the market and many more opportunities for treatment.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Neurodiagnostics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Neurodiagnostics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
High Costs of Neurodiagnostic Equipment is the major factors hampering the Neurodiagnostics Market growth.
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)
Asia Pacific region dominated the Neurodiagnostics Market in 2023
The Neurodiagnostics Market is estimated to witness a CAGR of 7.5% from 2023 to 2031
General Electric Company, Koninklijke Philips N V, Siemens Healthcare GmbH, Hitachi Ltd, Canon Medical Systems USA, Natus Medical Incorporated, NIHON KOHDEN CORPORATION are the major companies operating in the Neurodiagnostics Market
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional/country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neurodiagnostics Market - By Product
1.3.2 Neurodiagnostics Market - By Indication
1.3.3 Neurodiagnostics Market - By End User
1.3.4 Neurodiagnostics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEURODIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. NEURODIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEURODIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. NEURODIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. NEURODIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. NEURODIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. DIAGNOSTIC IMAGING SYSTEMS
7.3.1. Overview
7.3.2. Diagnostic Imaging Systems Market Forecast and Analysis
7.3.3. MRI Systems Market
7.3.3.1. Overview
7.3.3.2. MRI Systems Market Forecast and Analysis
7.3.4. EEG Systems Market
7.3.4.1. Overview
7.3.4.2. EEG Systems Market Forecast and Analysis
7.3.5. CT Scanners Market
7.3.5.1. Overview
7.3.5.2. CT Scanners Market Forecast and Analysis
7.3.6. PET Scanners Market
7.3.6.1. Overview
7.3.6.2. PET Scanners Market Forecast and Analysis
7.3.7. EMG Devices Market
7.3.7.1. Overview
7.3.7.2. EMG Devices Market Forecast and Analysis
7.3.8. Ultrasound Imaging Systems Market
7.3.8.1. Overview
7.3.8.2. Ultrasound Imaging Systems Market Forecast and Analysis
7.3.9. MEG Devices Market
7.3.9.1. Overview
7.3.9.2. MEG Devices Market Forecast and Analysis
7.3.10. Angiography Systems Market
7.3.10.1. Overview
7.3.10.2. Angiography Systems Market Forecast and Analysis
7.3.11. Others Market
7.3.11.1. Overview
7.3.11.2. Others Market Forecast and Analysis
7.4. CLINICAL DIAGNOSTIC INSTRUMENTS
7.4.1. Overview
7.4.2. Clinical Diagnostic Instruments Market Forecast and Analysis
7.4.3. PCR Instruments Market
7.4.3.1. Overview
7.4.3.2. PCR Instruments Market Forecast and Analysis
7.4.4. NGS Instruments Market
7.4.4.1. Overview
7.4.4.2. NGS Instruments Market Forecast and Analysis
7.4.5. Sanger Sequencers Market
7.4.5.1. Overview
7.4.5.2. Sanger Sequencers Market Forecast and Analysis
7.4.6. Others Market
7.4.6.1. Overview
7.4.6.2. Others Market Forecast and Analysis
7.5. REAGENTS AND CONSUMABLES
7.5.1. Overview
7.5.2. Reagents and Consumables Market Forecast and Analysis
7.5.3. Media and Sera Market
7.5.3.1. Overview
7.5.3.2. Media and Sera Market Forecast and Analysis
7.5.4. Antibodies Market
7.5.4.1. Overview
7.5.4.2. Antibodies Market Forecast and Analysis
7.5.5. Buffers Market
7.5.5.1. Overview
7.5.5.2. Buffers Market Forecast and Analysis
7.5.6. Solvents Market
7.5.6.1. Overview
7.5.6.2. Solvents Market Forecast and Analysis
7.5.7. Enzymes Proteins Market
7.5.7.1. Overview
7.5.7.2. Enzymes Proteins Market Forecast and Analysis
7.5.8. Probes Market
7.5.8.1. Overview
7.5.8.2. Probes Market Forecast and Analysis
7.5.9. Others Market
7.5.9.1. Overview
7.5.9.2. Others Market Forecast and Analysis
8. NEURODIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. NEURODEGENERATIVE DISEASES
8.3.1. Overview
8.3.2. Neurodegenerative Diseases Market Forecast and Analysis
8.4. EPILEPSY
8.4.1. Overview
8.4.2. Epilepsy Market Forecast and Analysis
8.5. STROKE
8.5.1. Overview
8.5.2. Stroke Market Forecast and Analysis
8.6. HEADACHE DISORDERS
8.6.1. Overview
8.6.2. Headache Disorders Market Forecast and Analysis
8.7. SLEEP DISORDERS
8.7.1. Overview
8.7.2. Sleep Disorders Market Forecast and Analysis
9. NEURODIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND SURGICAL CENTERS
9.3.1. Overview
9.3.2. Hospitals and Surgical Centers Market Forecast and Analysis
9.4. DIAGNOSTIC LABORATORIES AND IMAGING CENTERS
9.4.1. Overview
9.4.2. Diagnostic Laboratories and Imaging Centers Market Forecast and Analysis
9.5. NEUROLOGY CENTERS
9.5.1. Overview
9.5.2. Neurology Centers Market Forecast and Analysis
9.6. AMBULATORY CARE CENTERS
9.6.1. Overview
9.6.2. Ambulatory Care Centers Market Forecast and Analysis
9.7. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
9.7.1. Overview
9.7.2. Research Laboratories and Academic Institutes Market Forecast and Analysis
10. NEURODIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Neurodiagnostics Market Overview
10.1.2 North America Neurodiagnostics Market Forecasts and Analysis
10.1.3 North America Neurodiagnostics Market Forecasts and Analysis - By Product
10.1.4 North America Neurodiagnostics Market Forecasts and Analysis - By Indication
10.1.5 North America Neurodiagnostics Market Forecasts and Analysis - By End User
10.1.6 North America Neurodiagnostics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Neurodiagnostics Market
10.1.6.1.1 United States Neurodiagnostics Market by Product
10.1.6.1.2 United States Neurodiagnostics Market by Indication
10.1.6.1.3 United States Neurodiagnostics Market by End User
10.1.6.2 Canada Neurodiagnostics Market
10.1.6.2.1 Canada Neurodiagnostics Market by Product
10.1.6.2.2 Canada Neurodiagnostics Market by Indication
10.1.6.2.3 Canada Neurodiagnostics Market by End User
10.1.6.3 Mexico Neurodiagnostics Market
10.1.6.3.1 Mexico Neurodiagnostics Market by Product
10.1.6.3.2 Mexico Neurodiagnostics Market by Indication
10.1.6.3.3 Mexico Neurodiagnostics Market by End User
10.2. EUROPE
10.2.1 Europe Neurodiagnostics Market Overview
10.2.2 Europe Neurodiagnostics Market Forecasts and Analysis
10.2.3 Europe Neurodiagnostics Market Forecasts and Analysis - By Product
10.2.4 Europe Neurodiagnostics Market Forecasts and Analysis - By Indication
10.2.5 Europe Neurodiagnostics Market Forecasts and Analysis - By End User
10.2.6 Europe Neurodiagnostics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Neurodiagnostics Market
10.2.6.1.1 Germany Neurodiagnostics Market by Product
10.2.6.1.2 Germany Neurodiagnostics Market by Indication
10.2.6.1.3 Germany Neurodiagnostics Market by End User
10.2.6.2 France Neurodiagnostics Market
10.2.6.2.1 France Neurodiagnostics Market by Product
10.2.6.2.2 France Neurodiagnostics Market by Indication
10.2.6.2.3 France Neurodiagnostics Market by End User
10.2.6.3 Italy Neurodiagnostics Market
10.2.6.3.1 Italy Neurodiagnostics Market by Product
10.2.6.3.2 Italy Neurodiagnostics Market by Indication
10.2.6.3.3 Italy Neurodiagnostics Market by End User
10.2.6.4 Spain Neurodiagnostics Market
10.2.6.4.1 Spain Neurodiagnostics Market by Product
10.2.6.4.2 Spain Neurodiagnostics Market by Indication
10.2.6.4.3 Spain Neurodiagnostics Market by End User
10.2.6.5 United Kingdom Neurodiagnostics Market
10.2.6.5.1 United Kingdom Neurodiagnostics Market by Product
10.2.6.5.2 United Kingdom Neurodiagnostics Market by Indication
10.2.6.5.3 United Kingdom Neurodiagnostics Market by End User
10.2.6.6 Rest of Europe Neurodiagnostics Market
10.2.6.6.1 Rest of Europe Neurodiagnostics Market by Product
10.2.6.6.2 Rest of Europe Neurodiagnostics Market by Indication
10.2.6.6.3 Rest of Europe Neurodiagnostics Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Neurodiagnostics Market Overview
10.3.2 Asia-Pacific Neurodiagnostics Market Forecasts and Analysis
10.3.3 Asia-Pacific Neurodiagnostics Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Neurodiagnostics Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Neurodiagnostics Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Neurodiagnostics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Neurodiagnostics Market
10.3.6.1.1 Australia Neurodiagnostics Market by Product
10.3.6.1.2 Australia Neurodiagnostics Market by Indication
10.3.6.1.3 Australia Neurodiagnostics Market by End User
10.3.6.2 China Neurodiagnostics Market
10.3.6.2.1 China Neurodiagnostics Market by Product
10.3.6.2.2 China Neurodiagnostics Market by Indication
10.3.6.2.3 China Neurodiagnostics Market by End User
10.3.6.3 India Neurodiagnostics Market
10.3.6.3.1 India Neurodiagnostics Market by Product
10.3.6.3.2 India Neurodiagnostics Market by Indication
10.3.6.3.3 India Neurodiagnostics Market by End User
10.3.6.4 Japan Neurodiagnostics Market
10.3.6.4.1 Japan Neurodiagnostics Market by Product
10.3.6.4.2 Japan Neurodiagnostics Market by Indication
10.3.6.4.3 Japan Neurodiagnostics Market by End User
10.3.6.5 South Korea Neurodiagnostics Market
10.3.6.5.1 South Korea Neurodiagnostics Market by Product
10.3.6.5.2 South Korea Neurodiagnostics Market by Indication
10.3.6.5.3 South Korea Neurodiagnostics Market by End User
10.3.6.6 Rest of Asia-Pacific Neurodiagnostics Market
10.3.6.6.1 Rest of Asia-Pacific Neurodiagnostics Market by Product
10.3.6.6.2 Rest of Asia-Pacific Neurodiagnostics Market by Indication
10.3.6.6.3 Rest of Asia-Pacific Neurodiagnostics Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Neurodiagnostics Market Overview
10.4.2 Middle East and Africa Neurodiagnostics Market Forecasts and Analysis
10.4.3 Middle East and Africa Neurodiagnostics Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Neurodiagnostics Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Neurodiagnostics Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Neurodiagnostics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Neurodiagnostics Market
10.4.6.1.1 South Africa Neurodiagnostics Market by Product
10.4.6.1.2 South Africa Neurodiagnostics Market by Indication
10.4.6.1.3 South Africa Neurodiagnostics Market by End User
10.4.6.2 Saudi Arabia Neurodiagnostics Market
10.4.6.2.1 Saudi Arabia Neurodiagnostics Market by Product
10.4.6.2.2 Saudi Arabia Neurodiagnostics Market by Indication
10.4.6.2.3 Saudi Arabia Neurodiagnostics Market by End User
10.4.6.3 U.A.E Neurodiagnostics Market
10.4.6.3.1 U.A.E Neurodiagnostics Market by Product
10.4.6.3.2 U.A.E Neurodiagnostics Market by Indication
10.4.6.3.3 U.A.E Neurodiagnostics Market by End User
10.4.6.4 Rest of Middle East and Africa Neurodiagnostics Market
10.4.6.4.1 Rest of Middle East and Africa Neurodiagnostics Market by Product
10.4.6.4.2 Rest of Middle East and Africa Neurodiagnostics Market by Indication
10.4.6.4.3 Rest of Middle East and Africa Neurodiagnostics Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Neurodiagnostics Market Overview
10.5.2 South and Central America Neurodiagnostics Market Forecasts and Analysis
10.5.3 South and Central America Neurodiagnostics Market Forecasts and Analysis - By Product
10.5.4 South and Central America Neurodiagnostics Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Neurodiagnostics Market Forecasts and Analysis - By End User
10.5.6 South and Central America Neurodiagnostics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Neurodiagnostics Market
10.5.6.1.1 Brazil Neurodiagnostics Market by Product
10.5.6.1.2 Brazil Neurodiagnostics Market by Indication
10.5.6.1.3 Brazil Neurodiagnostics Market by End User
10.5.6.2 Argentina Neurodiagnostics Market
10.5.6.2.1 Argentina Neurodiagnostics Market by Product
10.5.6.2.2 Argentina Neurodiagnostics Market by Indication
10.5.6.2.3 Argentina Neurodiagnostics Market by End User
10.5.6.3 Rest of South and Central America Neurodiagnostics Market
10.5.6.3.1 Rest of South and Central America Neurodiagnostics Market by Product
10.5.6.3.2 Rest of South and Central America Neurodiagnostics Market by Indication
10.5.6.3.3 Rest of South and Central America Neurodiagnostics Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NEURODIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. GENERAL ELECTRIC COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. KONINKLIJKE PHILIPS N.V.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SIEMENS HEALTHCARE GMBH
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. HITACHI, LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CANON MEDICAL SYSTEMS, USA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NATUS MEDICAL INCORPORATED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NIHON KOHDEN CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ADVANCED BRAIN MONITORING, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. LIFELINES NEURO COMPANY, LLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MITSAR CO., LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
- General Electric Company
- Koninklijke Philips N.V.
- Siemens Healthcare GmbH
- Hitachi, Ltd.
- Canon Medical Systems, USA
- Natus Medical Incorporated
- NIHON KOHDEN CORPORATION
- Advanced Brain Monitoring, Inc.
- Lifelines Neuro Company, LLC
- Mitsar Co., Ltd.
- Thermo Fisher Scientific, Inc.
- ANT Neuro
- Neusoft Medical Systems Co., Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For